Nature Reviews Urology

Papers
(The median citation count of Nature Reviews Urology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Top, bottom or vers? Creating a more equitable health system for sexual and gender minority patients with prostate cancer140
CDH12-expressing cell population predicts patient response to therapy123
Krause corpuscles act as genital vibration detectors115
Exploratory results from the CheckMate 214 trial108
Immune infiltration associated with outcomes107
Semen quality recovery following COVID-1983
Novel intravesical gemcitabine delivery system (TAR-200) for neoadjuvant treatment of MIBC: context is everything72
Texture analysis for patient selection68
Single-cell and spatial sequencing of kidney cancer66
Human-relevant urothelial model provides insight into infection strategies and host response64
Sexual recovery interventions following prostate cancer treatment55
Time for women-centred gynaecology52
RAL-P in infants: expert tips for success51
High-dose chemotherapy for relapsed testicular germ cell tumours51
Implementation of patient-reported outcome measures into health care for men with localized prostate cancer50
Advancing the state of the art in congenital obstructive uropathy50
Preclinical models of bladder cancer: BBN and beyond50
HIV pre-exposure prophylaxis and sexually transmitted infections: intersection and opportunity48
PARP inhibitors plus enzalutamide to treat mCRPC47
Urine microbiota differ in bladder cancer46
Host–biomaterial interactions in mesh complications after pelvic floor reconstructive surgery45
Considering urology in a planetary context45
The potential of CAR T cell therapy for prostate cancer44
A clinical guide to rare male sexual disorders44
Proteomic-based analysis of testicular interstitial fluid42
Understanding recurrence in chromophobe RCC41
A new text message-based platform for self-management of patients with IC/BPS41
Prevalence of gender dysphoria in Japan41
Microfluidic sperm selection41
FOXA2–KIT-driven lineage plasticity in NEPC41
Evolution of the World Health Organization semen analysis manual: where are we?39
Ibrexafungerp to treat acute vulvovaginal candidiasis39
Madrid plays host to a celebration of urology37
Reducing the stigma of academic mental health can save lives36
Overcoming antibiotic resistance in complicated UTI36
Is SARS-CoV-2-induced testicular damage in hamsters relevant?34
Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer34
The evolving landscape of monogenic nephrolithiasis and therapeutic innovations33
Galectins as potential therapeutic targets in STIs in the female genital tract33
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers32
A non-invasive assay for UTUC diagnosis32
Metaverse in surgery — origins and future potential32
Measuring and improving the cradle-to-grave environmental performance of urological procedures31
Mirabegron safe and effective for NDO31
Resolving the puzzle of same-sex sexual interactions31
Pembrolizumab + axitinib beyond first-line therapy for mRCC31
Incorporating palliative care principles to improve patient care and quality of life in urologic oncology30
Antibiotic therapy for treating overactive bladder is not supported by clinical evidence30
177Lu–PSMA-PET extends survival29
Quality checkpoints in the MRI-directed prostate cancer diagnostic pathway29
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment29
COVID can’t kill CopMich collaboration27
Vaccination to prevent untreatable gonorrhoea27
The mechanism of action of neuromodulation in the treatment of overactive bladder26
Quest for a genetic biomarker for sickle cell disease priapism: rationale, progress and implications26
PEACEing together prostate cancer therapy25
Pain management in percutaneous nephrolithotomy — an approach rooted in pathophysiology25
Personalized 3D models for prostate cancer surgery25
Efficacy of the Revi system in treating urgency urinary incontinence25
Molecular events in neuroendocrine prostate cancer development24
Effect of high glucose on E. coli24
Robots learning to imitate surgeons — challenges and possibilities23
Is it time to rethink the current patient-reported outcome measures?23
Author Correction: Can PROMs improve racial equity in outcomes after prostatectomy?23
Sexual orientation, gender identity and COVID: a complicated picture22
Prostate cancer in transgender women — challenges in research and clinical care22
Secondary kidney stones — remove or leave?21
A clinical overview of people living with HIV and genitourinary cancer care21
Rucaparib improves PFS in patients with BRCA1/2-altered mCRPC21
A distinct TAM subset mediates immunotherapy resistance in prostate cancer20
Women in urology: the past20
Videourodynamics — role, benefits and optimal practice20
AUA returns to its former glory in Chicago20
Cribriform morphology affects mpMRI imaging20
Promising efficacy of UTI vaccines as an alternative to antibiotics20
Successful mentorship for women in urology — a new era20
The magic of MagSToNE20
Current and emerging strategies to curb antibiotic-resistant urinary tract infections19
Microultrasonography-guided prostate cancer biopsy19
Centralization of care for rare genetic syndromes associated with cancer: improving outcomes and advancing research on VHL disease19
The placebo and nocebo effects in functional urology19
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards18
Androgen receptor pathway inhibitor combination in prostate cancer18
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer18
Metabolic response to immunotherapy in prostate cancer18
Long-term OS and safety data from IMvigor21117
Going in circles: circMGA–HNRNPL feedback loop in bladder cancer17
The evolving treatment landscape of metastatic urothelial cancer16
Management and cost of stent encrustation in pregnancy16
De-clear cell differentiated renal cell carcinoma — a new therapeutic target16
Turning up the heat: CTLA4 blockade in urothelial cancer15
Detecting lymph node metastases for personalized radiotherapy in patients with prostate cancer15
Evolving language reflects evolving understanding: updated terms for anatomical description in i/VSC/DSD14
Using oncolytic viruses to ignite the tumour immune microenvironment in bladder cancer14
The future of patient-derived xenografts in prostate cancer research14
Overall survival with adjuvant pembrolizumab in renal cell carcinoma — the shock of the lightning14
Recurrence mechanisms of non-muscle-invasive bladder cancer — a clinical perspective13
Immune-based therapies in penile cancer13
Breaking the silence: normalizing receptive anal intercourse for patients, for people and for myself12
The prognostic role of stroma in UTUC11
The value of women urologists — individual and institutional imperatives to address salary equity11
We all get erections — de-gendering sexual arousal dysfunction in the ICD10
Hypoxia-inducible factor 2 inhibitors show promise in advanced kidney cancer10
The unclear role of PET–CT in localized radiorecurrent prostate cancer10
Uncovering a link between COVID-19 and renal cell carcinoma10
The shifting treatment paradigm of metastatic renal cell carcinoma10
Hallmark discoveries in the biology of Wilms tumour9
Prostate cancer screening: a new way forward or another false start?9
BAUSing back in Birmingham9
Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer9
Improved phenotypic classification of male infertility to promote discovery of genetic causes9
Vitamins as regulators of calcium-containing kidney stones — new perspectives on the role of the gut microbiome9
CMA mediates resistance to androgen inhibitors in prostate cancer8
Men hold the balance of power8
Tuft cells in prostate cancer8
Understanding iGCA8
Power up to investigate PrEP8
Mitomycin C plus cytosine arabinoside for NMIBC8
Effects of COVID-19 vaccine on semen parameters8
Patient selection is key in IMbassador2508
Male infertility and somatic health — insights into lipid damage as a mechanistic link7
Mellow yellow: BilR reduces bilirubin to urobilinogen7
Microbiota manipulation to prevent oxalate kidney stone formation7
Diagnosis of ccRCC7
ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer7
Salvage therapy for prostate cancer after radical prostatectomy7
Metabolism, mitochondria and metastasis in kidney cancer7
Human kidney stones: a natural record of universal biomineralization7
Mechanisms of the intestinal and urinary microbiome in kidney stone disease6
Immune dysfunction and reprogramming in RCC6
Sperm activity affected by endometriosis6
Spatiotemporal trends in human semen quality6
MRI diagnosis and radical prostatectomy outcomes6
A prompt-based stewardship to reduce extended-spectrum antibiotic treatment in UTI6
Semen parameters across testicular cancer stages6
Mechanisms of the Supra-T paradox6
Rising Black voices in urology — the next generation6
The ins and outs of penile erection5
Syphilis on the rise — a need for alternative therapies and vaccines5
Particulate matter leaves a bitter taste in testes5
Influence of substance use on male reproductive health and offspring outcomes5
Urology on a changing planet: links between climate change and urological disease5
Genetic ancestry and racial differences in prostate tumours5
Chlorination by-products in drinking water — association with bladder cancer risk5
Stepping up to prevent bacterial vaginosis recurrence5
Probiotics to treat chronic bacterial prostatitis5
Clinical trial design for non-muscle-invasive bladder cancer5
Toilet-based continuous health monitoring using urine5
Practical considerations for prostate hypofractionation in the developing world5
Advances in sliding clip renorrhaphy for partial nephrectomy5
Prostate luminal progenitor cells: from mouse to human, from health to disease5
A great gathering at the 4th Clinical and Scientific Advances in UTI conference5
Artificial intelligence in the management of prostate cancer5
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma4
ADT intensification to treat biochemically recurrent prostate cancer4
Genetic and biological drivers of prostate cancer disparities in Black men4
Author Correction: Advances in sperm analysis: techniques, discoveries and applications4
The future of pelvic lymph node dissection for urological malignancies4
The prostatic middle lobe: clinical significance, presentation and management4
Improving care for transgender and non-binary individuals4
Von Hippel–Lindau protein signalling in clear cell renal cell carcinoma4
Being a non-native English speaker in science and medicine4
Pregnancy and parental leave in medicine and academia — a focus on urology4
Exploring the impact of lipid stress on sperm cytoskeleton: insights and prospects4
Gut microbiome’s effect on immunotherapy response4
Feasibility and potential of an MRI-based prostate cancer screening4
Mutagenic effect of chemotherapy on sperm DNA and implications for family planning4
The effects of diet on prostate cancer outcomes4
Prescribing clinician specialty influences adherence to PrEP4
Reply to ‘Management of very young fetuses with LUTO’3
Managing autonomic dysreflexia during urological care in individuals living with spinal cord injury3
Urinary microbiota associated with OAB symptoms3
Proteomic characterization of bladder cancer3
The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications3
GDF15 blockade can reduce immunotherapy resistance in urothelial cancer3
CRISPR–Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer3
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research3
Sexual transfer of bacteria for forensic use3
Optimizing cystoscopy and TURBT: enhanced imaging and artificial intelligence3
Can systematic biopsy be omitted from the prostate cancer diagnostic pathway?3
Landmarks in the evolution of prostate biopsy3
A vagina on a chip to model microbiome–host interactions3
Sex differences in bladder cancer: emerging data and call to action3
The effect of red blood cell disorders on male fertility and reproductive health3
Patient-reported outcomes in metastatic renal cell carcinoma trials using combinations versus sunitinib as first-line treatment3
An app for optimizing UTI screening3
Bone marrow microenvironment in prostate cancer3
A new surgical procedure to treat BPH3
Clinical hypnosis improves LUTS3
Prostate cancer epigenetics — from pathophysiology to clinical application3
Advancing perioperative care in MIBC: insights from NIAGARA3
Metastasis development in non-muscle-invasive bladder cancer3
New insights into APOBEC-mediated mutagenesis in prostate cancer3
Metabolic alterations drive enzalutamide resistance2
Evolving the surgical approach for bladder cancer — robotic versus open radical cystectomy2
Control of oncogenic signalling in ccRCC2
Robotic kidney transplantation2
Intestinal microbiota drive CRPC2
Body fluid-derived stem cells — an untapped stem cell source in genitourinary regeneration2
Utility of PSA screening in transgender women receiving oestrogens2
Proteomic discovery of non-invasive biomarkers of localized prostate cancer using mass spectrometry2
20 years of ‘spilling the tea’ in urology2
Understanding and integrating cytoreductive nephrectomy with immune checkpoint inhibitors in the management of metastatic RCC2
Camrelizumab plus famitinib to treat RCC2
Generative AI in scientific publishing: disruptive or destructive?2
UPEC-mediated alteration of host mitochondrial function — a survival strategy2
Author Correction: Advances in sliding clip renorrhaphy for partial nephrectomy2
Metabolic flexibility in ccRCC2
Effects of the environment on the evolution of the vertebrate urinary tract2
Abortion is a urology workforce issue2
Supplementary selenium and vitamin E in non-muscle-invasive bladder cancer2
Accessing information in the AI age2
Islatravir implant as HIV-1 pre-exposure treatment2
Perspectives in primary hyperoxaluria — historical, current and future clinical interventions2
Human sperm RNA in male infertility2
Bladder EpiCheck for NMIBC2
From foes to friends: rethinking the role of lymph nodes in prostate cancer2
Immunoliposome targeting IL-302
Microplastics in the penis2
Targeting TGCT2
Focusing on male infertility2
Intravesical ICIs to reduce toxicity in NMIBC2
Experimental in vitro, ex vivo and in vivo models in prostate cancer research2
Knockout of extended pelvic lymph node dissection during radical cystectomy2
NMIBC risk factors in patients treated with BCG2
Health-related quality of life after curative treatment for muscle-invasive bladder cancer2
The potential role of the microbiota in prostate cancer pathogenesis and treatment2
Promoting the health of men of all backgrounds: educating ourselves to build trust and improve care2
Road for inclusion and caring in urology starts at AUA 221
Prostate zones and cancer: lost in transition?1
Shared decision-making before prostate cancer screening decisions1
RNA N6-methyladenosine modifications in urological cancers: from mechanism to application1
Circulating and urinary tumour DNA in urothelial carcinoma — upper tract, lower tract and metastatic disease1
Embryonal origin of adult testicular macrophages1
Implications of testicular ACE2 and the renin–angiotensin system for SARS-CoV-2 on testis function1
Modelling AR mutations1
Urine biomarkers in bladder cancer — current status and future perspectives1
What is fuelling the monkeypox outbreak?1
In-service training programmes to enhance surgical capacity in a resource-limited setting1
Current state and future considerations for home uroflowmetry1
Artificial intelligence and urology: ethical considerations for urologists and patients1
E-cigarettes and erectile dysfunction1
First-morning urine samples to study the urobiome1
Cutting cholesterol curbs clear cell RCC1
Author Correction: Metaverse in surgery — origins and future potential1
Effect of smoking, hypertension and lifestyle factors on kidney cancer — perspectives for prevention and screening programmes1
Mechanisms of oxidative stress in interstitial cystitis/bladder pain syndrome1
Home-based exercise for men with mCRPC1
Artificial intelligence implementation in ESWL1
Immunoproteasome inhibition in CRPC1
0.32280683517456